Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
26359101000001115 | Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
107153001000001117 | Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Piramal Critical Care Ltd) 10 ampoule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 2 (CD) | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Is a | Alfentanil 5mg/1ml solution for injection ampoules 10 ampoule | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Is pack of | Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) | false | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has active ingredient | Alfentanil hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has active ingredient | Alfentanil | false | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has AMP | Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Alfentanil | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has specific active ingredient | Alfentanil hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
Rapifen Intensive Care 5mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) 10 ampoule 5 x 10ml ampoules | Has basis of strength substance | Alfentanil | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets